RaDVaC Data Explorer
Antiviral database
Virus Taxonomy
← Back to Dashboard
Azithromycin
2D Structure
Loading structure...
3D Structure
Loading 3D structure...
Chemical Identifiers
SMILES:
CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC…
InChI Key:
MQTOSJVFKKJCRP-BICOPXKESA-N
ClinicalTrials.gov
PubMed
Clinical Development by Virus
10
Human orthopneumovirus
RSV
Target: Human (multiple)
Phase 3
Preclinical
Phase 2
positive
Phase 3
uncertain
Approved
Phase 2 ref (Ref)
Phase 3 ref (researchgate.net)
NCT02911935
NCT02911935
Severe acute respiratory syndrome-related coronavirus
SARS-CoV-2
Target: Human (multiple)
Phase 3
Preclinical
Phase 2
positive
Phase 3
negative
Approved
Phase 3 ref (Ref)
PMID:33676597
Influenza A virus
FLUAV
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
NCT01779570
Zaire ebolavirus
EBOV
Target: Human (multiple)
Phase 2
Preclinical
Phase 2
Phase 3
Approved
PMID:27622822
NCT02380625
Human immunodeficiency virus 1
HIV-1
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
NCT04036318
NCT01227395
Enterovirus A
EV-A71
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:30599241
Rhinovirus A
HRV-A16
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:28415826
Hepacivirus C
HCV
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Ref
Enterovirus A
CV-A16
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:30599241
Zika virus
ZIKV
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:27911847